Clinical Trial Update: Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan

View source ↗

Summary

This entry provides a clinical trial update on dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia in Japan. The status of the trial is not spec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Sprycel (dasatinib)

Snippet

Sponsor: Kanto CML Study Group | Conditions: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myelogenous Leukemia, Chronic, Chronic Phase | Status: UNKNOWN